You and the process

With a person
Anna, in-house recruiter
9 years hiring engineers
30 minutes with a real recruiter
They read your CV with you, on a call, and say where the offers are being lost.
Didn’t find what you were looking for? Tell us what to build
AstraZeneca

Director, Oncology Commercial Data Science & AI Products

  • Hybrid
  • 6+ years

Salary

$186,014+/ year

AI summary

For members

The whole posting in a few lines. Sign up to read it here and on every role you open.

Sign Up to Read

Description

The company is building a connected enterprise AI engine that brings together data foundations, AI technology, process change and business-facing AI to speed results across the value chain. Success depends on people who connect teams, reuse existing capabilities, carry useful ideas across regions and functions, and measure impact by adoption and scale.

The DS&AI Products team inside the oncology business unit (OBU) builds AI products across their full lifecycle, including predictive field triggers, patient identification models, omnichannel next-best-action, KOL intelligence and GenAI field tools. The team ships working products rather than reports, and each capability must show measurable field adoption and commercial impact.

The director will own a multi-indication AI portfolio from start to finish, act as the DS&AI partner to brand and medical leaders, and oversee responsible design, delivery, adoption and impact measurement.

This is a product ownership and strategy role, not an analytics consulting role. You will write requirements, review GenAI architecture with engineering leads, run discovery with brand teams and present the roadmap to senior leadership. Solutions should be built for reuse, so a trigger framework proven in one tumor area can serve the next launch.

Posted 11-nov-2026. Closing date 26-nov-2026.

Responsibilities

  • Set and own the strategy and transformation roadmap for Sales, Marketing and Medical Affairs AI across your assigned OBU tumor areas, including planning and budget within the OBU annual cycle.
  • Build quantified business cases and value narratives for future AI capabilities with OBU Franchises, I&A and Enterprise AI delivery teams, then present them to the OBU Leadership Team (OLT) to align on roadmap priorities.
  • Keep a ranked product backlog with user stories, acceptance criteria and delivery timelines, balancing maintenance, new AI pilots and onboarding of new indications in an agile model.
  • Follow shifts in the industry, market and AI field, including GenAI, agentic AI, oncology data science and competitor activity, so the roadmap stays ahead of opportunities and risks.
  • Push a platform-first, reuse-first approach so capabilities piloted in one indication can scale across OBUs without rebuilding the platform.
  • Define, design and deliver GenAI applications for commercial and medical teams, including AI-assisted field briefing tools, clinical evidence summaries for MSLs, agentic omnichannel workflows and natural-language access to analytics.
  • Write product requirements and functional specifications for LLM, RAG and agentic applications, and work with Enterprise AI engineering leads to build governed, scalable, production-ready solutions.
  • Stay current on GenAI and agentic methods such as prompt engineering, RAG, multi-agent orchestration and evaluation, and judge architecture choices against OBU field workflows.
  • Run pilots with clear scope and success criteria set in advance, measure output quality and adoption, and make evidence-based decisions on scaling to other indications and functions.
  • Act as DS&AI business partner and product owner for assigned tumor-area brand teams, Medical Affairs and Market Access, joining strategy reviews, launches and leadership meetings as the AI lead.
  • Run cross-functional discovery workshops to uncover unmet decision needs, then scope AI use cases with problem statements, success metrics, data needs and risk tiers, and turn them into engineering user stories.
  • Work with MSL and medical leaders on scientific use cases such as treatment-pathway analytics, KOL and KEE influence mapping, diagnostic and biomarker testing strategies and health equity analysis.
  • Own demand-sensing and care-gap workstreams that feed FSIP, forecasting and field plans, and present roadmap and field impact at leadership, national sales and SteerCo meetings.
  • Lead change management for each AI capability, setting direction for how AI is built and embedded in daily field work and explaining the transformation to sales and marketing teams.
  • Work with Business Excellence and Franchise teams to plan training, field enablement workshops and role-specific onboarding for every major release.
  • Build AI literacy across brand, medical and field teams through reviews, lunch-and-learn sessions and executive briefings, and encourage self-service use of the company's AI platforms.
  • Translate business needs into technical requirements accurately and on time, and set a clear RACI that keeps priorities, dependencies and timelines aligned across the delivery model.
  • Deliver launch-critical AI outputs on schedule, including pre-launch analytics, ML-enriched targeting lists and predictive triggers built on EHR, claims and lab signals within the AIDLC framework.
  • Track progress across the portfolio, surface dependencies and blockers, and escalate issues to senior leaders with clear problem framing and suggested solutions.
  • Manage external vendors and consultants against agreed deliverables and timelines, and support budget management and PMO invoicing.
  • Identify and pilot new AI and ML methods for the portfolio, such as LLM field tools, agentic frameworks, biomarker signal models, multimodal data fusion and RWE analytics.
  • Lead or co-lead data source evaluations, explaining granularity limits and preprocessing needs to both technical and business audiences.
  • Design and run the OBU predictive ML trigger ecosystem for earlier patient identification, using reusable frameworks across tumor areas.
  • Design AI trigger frameworks that flag high-risk patients before clinical decision points, to shorten diagnostic and treatment lag.
  • Work within the company's enterprise AI governance framework, including registry before scale, model and data cards, human oversight, ongoing monitoring and IT approval.
  • Handle compliance, data access controls, HIPAA privacy requirements and vendor management for all OBU AI use cases, and make sure every product is deployed responsibly with full documentation.
  • Work with OBEX, FSIP, Legal, Privacy and I&A to keep AI-ready data assets such as enriched claims, EHR and MMIT compliant, auditable and run on standard quality checks and refresh cycles.
  • Keep the AIDLC auditable, with gates for UAT, compliance approval and release, scenario-based stakeholder demos and documented acceptance criteria.
  • Set success criteria and KPIs before launch, then track adoption, trigger execution, noise reduction and coverage, output quality and downstream results such as sales lift, speed of patient identification and care-gap closure.
  • Lead causal-impact studies to measure commercial lift from triggers and AI tools, and use the results to guide cross-OBU collaboration and investment decisions.
  • Explain product performance to OBU and enterprise leaders as business impact, using findings to support AI investment and future roadmap priorities.

Requirements

  • A bachelor's degree or equivalent experience in a quantitative field such as computer science, statistics, engineering or economics.
  • 7-10+ years of professional experience, including 5+ years in pharma commercial functions or pharma-focused strategy consulting, with end-to-end AI or data science product ownership that delivered measurable commercial impact in oncology or specialty settings.
  • Strong analytical skills to translate between brand strategy, commercial operations, data science and technology teams, and experience bridging business and technical stakeholders in a highly matrixed setting.
  • Hands-on experience with LLMs, prompt design, retrieval-augmented generation and agentic frameworks such as LangChain, LlamaIndex or similar, plus working Python skills, ML tooling and experience with a cloud platform such as AWS SageMaker or Athena, Databricks, Azure or GCP.
  • Deep knowledge of oncology commercial data, including secondary claims (IQVIA, Symphony, MMIT), EHR sources such as Komodo and Veeva PULSE, lab and diagnostic data such as Diaceutics, specialty pharmacy data and enriched ML datasets.
  • Excellent communication skills and a proven record of working well in highly matrixed organizations, with a consultative and relationship-focused style.
  • Self-starting, able to grasp core business goals, set direction, build alignment and move work forward, and resourceful and influential in a fast-growing organization.
  • Preferred: a graduate degree such as an MBA, MS, MD or PhD in a quantitative, scientific or business field.
  • Preferred: demonstrated commercial experience in oncology.
  • Preferred: production GenAI or agentic AI experience in commercial pharma, such as LLM field tools, RAG clinical applications or agentic omnichannel automation under enterprise governance.
  • Preferred: experience with KOL or KEE influence analytics, precision-targeting tools such as EGFR testing waypoint analysis, or omnichannel next-best-action platforms such as Aktana or Veeva Align.
  • Preferred: a record of leading AI-enabled transformation and change programs across large organizations of 1,000+ users.
  • Preferred: external thought leadership, such as conference talks or publications on oncology analytics or commercial AI.
  • Ideal: applied depth in LLMs and prompt engineering with GPT-4, Claude or Gemini models, including system prompts, few-shot and chain-of-thought methods and structured output.
  • Ideal: RAG design with vector stores, chunking strategies, retrieval evaluation and hallucination mitigation, plus LLMOps practice in evaluation pipelines, output monitoring and A/B testing.
  • Ideal: classical ML including logistic regression, gradient boosting such as XGBoost or LightGBM, clustering and propensity scoring for patient or HCP targeting.
  • Ideal: time-series and sequence models for patient journey stage prediction and trigger timing, and causal inference with test-and-control designs for AI impact and ROI.
  • Ideal: familiarity with oncology data sources such as IQVIA (NPA, XPONENT, DDD), Symphony, MMIT, SaleSEER, Komodo, Veeva PULSE, Diaceutics and Definitive Health.
  • Ideal: cloud and tooling skills across AWS (S3, Athena, SageMaker, Bedrock), Databricks, Snowflake, Python, SQL, R, SAS, Tableau, Power BI and Alteryx.
  • Ideal: agile delivery skills including backlog grooming, sprint planning, user stories, acceptance criteria, UAT management and release approval.
  • Ideal: AI governance skills such as model and data cards, registry workflows, compliance documents and evidence frameworks.
  • Ideal: UX collaboration through wireframes, user research, personas and prototype feedback with field and HQ teams, plus omnichannel work such as trigger code design, message alignment and field activation workflows.

Conditions

Office working: a minimum of 3 days per week on average in the office, with some flexibility for individual needs.

Annual base pay ranges from $186.014,40 - 279.021,60 USD per year, or the equivalent hourly rate (annual base pay divided by 2080 hours). Actual pay depends on factors such as market location, job knowledge, skills and experience.

Non-exempt hourly employees receive overtime pay for qualifying overtime hours.

This is an at-will position, and the company may change base pay or other discretionary pay at any time, based on individual or team performance and market conditions.

The posting does not state whether visa sponsorship is offered.

The company welcomes applications from all qualified candidates regardless of protected characteristics, and offers accommodations on request through the application form.

Benefits

  • Short-term incentive bonus opportunity.
  • Equity-based long-term incentive program for salaried roles.
  • Retirement contribution for hourly roles.
  • Commission eligibility for sales roles.
  • Qualified 401(k) retirement plan.
  • Paid vacation, holidays and leave.
  • Health coverage including medical, prescription drug, dental and vision, under the terms of each plan. Plan details are provided with an offer.

Where you’d work

Hybrid, 3 days a week in the office

You can work from

  • United States

About the company

AstraZeneca

  • Industry: HealthTech

Office in United States

Also hiring in Barcelona, Spain, Bucharest, Romania, Sweden and 8 more places

Your chances

We've checked whether it's still hiring and how crowded it is.

  • 22 checks run
  • 0 red flags

Still hiring?

15 checks

No red flags

How crowded?

7 checks

No red flags

Fits Me

How well does this role fit you?

Answer a few questions or drop your CV, and every role gets a fit score with the reasons, this one first.

  • Your field
  • Level
  • Stack
  • Work model
  • Salary floor
  • Must-haves
Details15 facts · Role, Location, Compensation, Employment, Company
Tech stack
  • Python
  • SQL
  • AWS
  • Tableau
  • Azure
  • Databricks
  • Snowflake
  • Power BI
  • LLMs
  • RAG
  • LangChain
  • Vector databases
Seniority
Director
Type
Full-time
Equity
Equity offered
Industry
HealthTech
Specialty
Data Science
Show 9 more factsShow less

Role

Category
Data & Analytics
Specialty
Data Science
Seniority
Director
Experience
10+ years
Tech stack
  • Python
  • SQL
  • AWS
  • Tableau
  • Azure
  • Databricks
  • Snowflake
  • Power BI
  • LLMs
  • RAG
  • LangChain
  • Vector databases

Location

Work model
Hybrid
Region
United States
Office
  • United States
Remote from
  • United States
Days in the office
3 days

Compensation

Salary
$186,014+ / year
Pay period
Annual
Equity
Equity offered

Employment

Type
Full-time

Company

Industry
HealthTech

Something wrong with this vacancy?

Similar vacancies

Share this vacancy

What's wrong with it?

The employer never sees who reported.

Reason